Stephen Wilson

Chief Executive Officer

Stephen Wilson is the Chief Executive Officer of Foundation Immune Engineering and the Botnar Institute of Immune Engineering. He is an Associate Clinical Professor at the University of California, San Diego, and former EVP/COO of La Jolla Institute for Immunology. His prior research focused on autoimmune and infectious disease developing rapid diagnostics (2021 X-Prize), oncology diagnostics (Invivoscribe, Inc), and global-scale immunoinformatics (co-PI of the NIH’s Immune Epitope Database).